IL17A and tuberculosis: With regard to experimental TB, administration of sgp130Fc to mice during the acute or chronic phase of Mtb infection has no significant effect on the expression of the effector cytokines TNF, IL-6, IFNγ and IL-17A, whereas it slightly hampers the release of IL-12/23p40 [169] (Figure 3A).